Login

MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated

MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated

mbs303 Resmi

MEREK : mbs303

MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated

mbs303mbs303cd3cd20t MBS303MBS-303: a CD20 inhibitors, CD3 stimulants Drug, Initially developed by Beijing Mabworks Biotech Co., Ltd.,

IDR 10.000

IDR 100.000 Disc -90%

Kuantitas